Assessment of the Predictive Value of the Acetic Acid Test in Surgery Condition for the Detection of Dysplastic Lesions in Patients With Anal Condylomatosis
1 other identifier
interventional
109
1 country
1
Brief Summary
Anal condylomatosis is an anal canal mucosa pathology caused by HPV infection (Human Papilloma Virus). This condition is common, especially in immunodepressed patients. These lesions are not accessible to topical medical treatment because of their location. They should be treated surgically because they may degenerate into squamous cell carcinoma. In the operating room, lesions are identified by a complete proctologic examination, more or less supplemented by an acetic acid test. Acetic acid allows to detect mucous degeneration (dysplasia) in the form of intense bleaching. The interpretation of this test may nevertheless be difficult in case of local inflammation or scarring. These false positives may lead to unnecessary surgical gestures. The surgical procedure consists of a mucosectomy or destruction of the condylomatosis by electrocoagulation. The acetic acid test is used at the discretion of the surgeon. However, there is little data on its performance or consensus on its use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 7, 2017
CompletedFirst Submitted
Initial submission to the registry
April 19, 2017
CompletedFirst Posted
Study publicly available on registry
April 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2018
CompletedJanuary 14, 2019
January 1, 2019
1.4 years
April 19, 2017
January 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Positive predictive value of the acetic acid test in comparison with the anatomopathological analysis of the biopsies performed on the lesions revealed by acetic acid
Application of acetic acid just before surgery to identify suspect areas of dysplasia. Biopsies of suspicious areas bleached with acetic acid. The true positives (TP) will correspond to lesions bleached by acetic acid and showing dysplasia at biopsy. False positives (FP) will correspond to lesions bleached by acetic acid but not showing dysplasia at biopsy. The positive predictive value (PPV) will be the proportion of TP over the total number of bleached lesions. (PPV = TP / (TP + FP)). The PPV will be given with its 95% confidence interval (95%CI).
the day of surgery
Secondary Outcomes (7)
Evaluation of the toxicity of the acetic acid test
the day of surgery
Identify a patient subgroup in which the acetic acid test would be particularly discriminatory
up to 5 months before surgery
post-surgery pain
up to 1 month post surgery
change in post-surgery incontinence
up to 5 months before surgery and 1 month post surgery
Clinical recurrence of anal condylomatosis
1 month post surgery
- +2 more secondary outcomes
Study Arms (1)
acetic acid test
OTHERPatients will receive surgical treatment for anal condylomatosis and acetic acid on the mucosa of the anal canal before the surgical procedure
Interventions
Patients will receive acetic acid on the mucosa of the anal canal before the surgical procedure
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- programmed surgery for anal condylomatosis in the visceral surgery department of the Hôpital de la Croix Rousse in Lyon
- patient in receipt of the social security scheme
- patient who did not oppose his participation in the study.
You may not qualify if:
- Pregnant women
- Patients protected by law
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hopital de la Croix Rousse
Lyon, 69004, France
Study Officials
- PRINCIPAL INVESTIGATOR
Benjamin Darnis
Hospices Civils de Lyon
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 19, 2017
First Posted
April 24, 2017
Study Start
March 7, 2017
Primary Completion
July 31, 2018
Study Completion
July 31, 2018
Last Updated
January 14, 2019
Record last verified: 2019-01